Varian

Berkeley Lights, Inc. is a digital cell biology company based in Emeryville, California, established in 2011. The company specializes in the rapid development and commercialization of biotherapeutics and other cell-based products. Berkeley Lights offers an integrated platform that includes proprietary consumables such as OptoSelect chips and reagent kits, along with automation systems and application software. Utilizing innovative micro-droplet technology, the company transforms biological processes, enabling researchers to study cell interactions more effectively. This platform supports various applications, including biotherapeutic discovery and development, cellular therapy manufacturing, and synthetic biology, addressing the growing demands in these fields.

Epic Sciences is a diagnostics company focused on cancer management through blood-based tests that identify and characterize circulating tumor cells from a minimally invasive sample. Its platform profiles single-cell phenotype and genotype, including biomarker expression levels, subcellular localization, morphologic features, and genotypic metrics, and supports next-generation sequencing, FISH, and single-cell genomics to detect and characterize CTCs. The company develops tests such as the Oncotype DX AR-V7 Nucleus Detect for metastatic castration-resistant prostate cancer and offers biopharma solutions. It collaborates with biotechnology and pharmaceutical companies and cancer centers worldwide to provide real-time biopsy material and data to guide personalized medicine. By enabling analysis of rare cells before and after treatment, Epic Sciences aims to improve cancer management. The company was founded in 2008 and is headquartered in San Diego, California.

Creates, sells, and supports phramaceutical chromatography systems and consumables

LipoScience is a Raleigh, North Carolina-based company specializing in personalized diagnostics through the use of nuclear magnetic resonance (NMR) technology. The company has developed the NMR LipoProfile test, its flagship diagnostic tool, which quantitatively measures low density lipoprotein particles (LDL-P) in blood samples. This test provides physicians and patients with critical information to tailor heart disease risk management effectively. Since its inception, LipoScience has seen significant adoption, with over 8 million NMR LipoProfile tests ordered to date.